Top Stories
A picture inside an empty theatre in Netflix's Tokyo office with Netflix logo on the screen

Netflix Stock Price Soars After Earnings Report Record New Memberships

Netflix stock price ( NASDAQ: NFLX ) is up more than 13% in the after-hours following its release of the fourth-quarter earnings report for fiscal year 2024. The streaming company recorded a 16% increase in revenue year-over-year, reaching 19% on a foreign exchange (F/X) neutral basis, which the

A smartphone on a surface showing Chipotle ad on screen

If you invested $1000 in Chipotle Mexican Grill (NYSE:CMG) 5 years ago, here's how much it's worth today

They say, “If it looks like a restaurant, cooks food like a restaurant, and serves food like a restaurant, then it’s probably a restaurant.”. However, this might not be how investors see Chipotle Mexican Grill ( NYSE:CMG ). Chipotle’s stock is currently trading at a P/E ratio of around 54, while many

Latest News

OneMedNet Reports Strong Momentum and Industry Excitement at RSNA

GlobeNewswire Inc.

MINNEAPOLIS, Dec. 10, 2025 (GLOBE NEWSWIRE) -- OneMedNet Corporation (Nasdaq: ONMD), the leading curator and provider of one of the world's largest regulatory-grade, AI-ready Real-World Data (RWD) network, today announced significant engagement and

American Rebel Holdings, Inc. (NASDAQ: AREB) Announces Fifth Pennsylvania Distributor – Ace Distributing – as American Rebel Light Beer’s Rapid Distribution Network Expansion Continues

GlobeNewswire Inc.

American Rebel Holdings Inc American Rebel Holdings, Inc. (NASDAQ: AREB) Announces Fifth Pennsylvania Distributor – Ace Distributing – as American Rebel Light Beer’s Rapid Distribution Network Expansion Continues Ace Distributing, a 75-year-old t

Sanara MedTech Inc. and Biomimetic Innovations Provide Update on OsStic™

GlobeNewswire Inc.

Poised for U.S. market launch in Q1 2027 following the achievement of recent milestones and OsStic’s granted patent in 2025 FORT WORTH, TX, Dec. 10, 2025 (GLOBE NEWSWIRE) -- Sanara MedTech Inc. (“Sanara,” the “Company,” “we,” “our” or “us”) (Nasdaq

IQSTEL Announces 2025 Accomplishments and Strategic Priorities for 2026 in New Interview

GlobeNewswire Inc.

2025 Achievements Lay Foundation for Accelerated 2026 Expansion NEW YORK, Dec. 10, 2025 (GLOBE NEWSWIRE) -- IQSTEL Inc. (NASDAQ: IQST) ("IQSTEL"), a leading provider of innovative telecommunications and technology solutions, today announced highlig

Journey Medical Corporation Announces Publication of Clinical Trial Results Assessing the Impact of Emrosi™ (DFD-29) on Microbial Flora of Healthy Adults in the Journal of Drugs in Dermatology

GlobeNewswire Inc.

Clinical trial achieved all three primary objectives with no significant safety issues being reported Results indicate that Emrosi can be safely used for up to 16 weeks with no detectable impact on skin, GI tract or vaginal microbiota FDA-approved Em

Veru to Report Fiscal Year 2025 Financial Results on December 17th

GlobeNewswire Inc.

MIAMI, FL, Dec. 10, 2025 (GLOBE NEWSWIRE) -- Veru Inc. (NASDAQ: VERU), a late clinical stage biopharmaceutical company focused on developing innovative medicines for the treatment of cardiometabolic and inflammatory diseases, today announced it wil

Lexicon Pharmaceuticals Announces Publication of Preclinical Data in the Journal of the Endocrine Society on Acyl-CoA Synthetase 5 (ACSL5) Reinforcing the Scientific Rationale for LX9851

GlobeNewswire Inc.

THE WOODLANDS, Texas, Dec. 10, 2025 (GLOBE NEWSWIRE) -- Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX) today announced the publication of preclinical data validating Acyl-CoA Synthetase 5 (ACSL5) as a target for obesity and chronic weight management.

FibroBiologics Files Patent Application Covering Novel Fibroblast-Based Chondrocyte Spheroid Platform for Orthopedic and Musculoskeletal Conditions

GlobeNewswire Inc.

Platform Poised to Expand into Joint and Cartilage RepairHOUSTON, Dec. 10, 2025 (GLOBE NEWSWIRE) -- FibroBiologics, Inc. (Nasdaq: FBLG) (“FibroBiologics” or the “Company”), a clinical-stage biotechnology company with 270+ patents issued and pending

Golden Rapture Increases Land Position at Its Newly Acquired Northern Queen Mine Property Adjacent to NexGold Mining & Dryden Gold Corp

Newsfile

Edmonton, Alberta--(Newsfile Corp. - December 10, 2025) - Golden Rapture Mining Corporation (CSE: GLDR) is pleased to announce that it has staked an additional 7 claim units at its 100% owned Northern Queen Mine property located southeast of Dryden,

Moleculin Announces Exercise of Warrants for $6.8 Million Gross Proceeds

GlobeNewswire Inc.

HOUSTON, Dec. 10, 2025 (GLOBE NEWSWIRE) -- Moleculin Biotech, Inc., (Nasdaq: MBRX) (“Moleculin” or the “Company”), a late-stage pharmaceutical company with a broad portfolio of drug candidates targeting hard-to-treat tumors and viruses, today annou